Tag: Susan Lee
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
Shared venture documentation gaps slow India funding rounds and shape foreign capital perceptions of ecosystem maturity
Trade secret protection under TSA and IPCAA: Secrecy, value, confidentiality measures and Supreme Court guidance
Follow us on LinkedIn